Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET) [Phase 1, Phase 2]
A clinical trial evaluating safety and efficacy of a tumor vaccine in patients with advanced renal cell carcinoma has completed Phase 1 and …
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery [Phase 3]
Phase 3 trial investigating targeted therapy with or without nephrectomy in metastatic clear-cell renal cell carcinoma; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma [Phase 2]
Phase 2 trial investigating anti-PD-1 combinations of D-CIK immunotherapy with axitinib in metastatic renal cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214) [Phase 3]
Phase 3 CheckMate 214 compared nivolumab plus ipilimumab versus sunitinib in previously untreated advanced or metastatic renal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Personalized Targeted Inhibitors Treatment in Renal Cell Cancer [Phase 2]
A Phase 2 clinical trial evaluating personalized targeted inhibitors for renal cell carcinoma was terminated; results were posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) [Phase 3]
Phase 3 trial comparing atezolizumab plus bevacizumab against sunitinib in untreated advanced renal cell carcinoma has completed with result…
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride given before surgery in patients with renal cell carcinoma has completed with posted result…
-
FDA approval · 2018-08-10FDA Approved: INLYTA — Supplemental Application (U.S. Pharmaceuticals)
The FDA approved a supplemental application for INLYTA (axitinib) submitted by U.S. Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) [Phase 1, Phase 2]
A combined alternating regimen of sunitinib and bevacizumab is being investigated in Phase 1/2 for advanced renal cell carcinoma in a clinic…
-
FDA approval · 2018-07-30FDA Approved: TEMSIROLIMUS — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original ANDA for temsirolimus, a generic version of the cancer drug used to treat advanced renal cell carc…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma [NA]
The document describes a clinical trial evaluating quality of life in daily clinical practice for patients with advanced renal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine plus irinotecan in locally advanced unresectable or metastatic renal cell carcinoma was terminated; res…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating pegylated interferon alfa-2b, sargramostim, and thalidomide in metastatic kidney cancer was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors [Phase 1]
Phase 1 study of nintedanib plus bevacizumab in advanced solid tumors has completed, assessing safety and preliminary activity across severa…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17) [EARLY_Phase 1]
A Phase 1 study evaluating intraoperative imaging of renal nodules in renal cell carcinoma using the folate-fluorescein conjugate EC17; the …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating APN401 in patients with metastatic or unresectable melanoma, pancreatic cancer, renal cell carcinoma, and other sol…
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]
The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy
This completed clinical trial compares prospective versus retrospective complication reporting in radical cystectomy and nephrectomy.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Rollover Protocol for Subjects Previously Treated With AGS-003 [Phase 2]
This clinical trial update notes a rollover protocol for previously treated subjects in a Phase 2 study of AGS-003 for renal cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with or without TRC105 in metastatic kidney cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients [Phase 2]
A Phase II study evaluating the efficacy and safety of TLC388 in patients with advanced/metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population [Phase 2]
A Phase 2 trial evaluating first-line sunitinib for advanced or metastatic Renal Cell Carcinoma in Asian patients was terminated.
-
CLINICAL_TRIALS withdrawal · 2018-06-18Clinical Trial Update: Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab [Phase 2]
An investigator-initiated Phase 2 trial evaluating the combination of ipilimumab, nivolumab, and stereotactic radiation for metastatic clear…
-
CLINICAL_TRIALS withdrawal · 2018-06-14Clinical Trial Update: Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma [Phase 3]
A Phase 3 trial of autologous dendritic cell immunotherapy plus standard treatment for advanced/metastatic renal cell carcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma [Phase 2]
Phase 2 study evaluating IMO-2055 for metastatic or locally recurrent clear cell renal cell carcinoma has completed and results are posted.